Biotechnology in Europe and Latin America : prospects for co-operation
Author(s)
Bibliographic Information
Biotechnology in Europe and Latin America : prospects for co-operation
Kluwer Academic for the Commission of the European Communities , Distributed in the U.S.A. and Canada by Kluwer Academic, c1989
Available at 9 libraries
  Aomori
  Iwate
  Miyagi
  Akita
  Yamagata
  Fukushima
  Ibaraki
  Tochigi
  Gunma
  Saitama
  Chiba
  Tokyo
  Kanagawa
  Niigata
  Toyama
  Ishikawa
  Fukui
  Yamanashi
  Nagano
  Gifu
  Shizuoka
  Aichi
  Mie
  Shiga
  Kyoto
  Osaka
  Hyogo
  Nara
  Wakayama
  Tottori
  Shimane
  Okayama
  Hiroshima
  Yamaguchi
  Tokushima
  Kagawa
  Ehime
  Kochi
  Fukuoka
  Saga
  Nagasaki
  Kumamoto
  Oita
  Miyazaki
  Kagoshima
  Okinawa
  Korea
  China
  Thailand
  United Kingdom
  Germany
  Switzerland
  France
  Belgium
  Netherlands
  Sweden
  Norway
  United States of America
Note
Includes papers presented at SOBELA, a Seminar on Biotechnology in Europe and Latin America, held Brussels, Apr. 1987
Description and Table of Contents
Description
The accession of Spain and Portugal to membership of the European Community in January 1985 not only brought new vitality to the European initiative, but served as a powerful reminder of the broader dimensions of the Spanish- and Portuguese-speaking worlds. A reinforcement of Europe's natural and historical interna tionalism of outlook was particularly relevant in the context of biotechnology; for the sophisticated multi-disciplinary scientific base, and the several broad application areas, force on biotechnol ogy an internationalism both for access to scientific capability, and for access to worldwide markets. Such was the rationale for 'SOBELA': a 'Seminar on Biotechnol ogy in Europe and Latin America', which in April 1987 brought some 50 Latin American entrepreneurs, policy-makers and academic leaders to Europe and to Brussels. At the Commission's Borschette Conference Centre, they heard presentations from eleven of the Community Member States, each emphasising its strengths in bio technology and its interest in promoting industrial collaboration with firms in Latin America. The seminar was opened by speeches from Vice-President Karl Heinz Narjes on behalf of the Commission, and by His Excellency Luis Ramiro Alfonsin of Argentina, senior Latin American diplomat in Brussels. In the closing session, Directors-General Paolo Fasella (Science, Research and Development, DG XII) and Jean Durieux (External Relations, DG I) welcomed Their Excellencies the ambas sadors from Argentina, Mexico, Brazil, Uruguay and Colombia.
Table of Contents
Section One: Biotechnology in Europe.- 1.0 Overview of European Activities in Biotechnology.- 1.1 Belgium.- 1.2 Denmark.- 1.3 France.- 1.4 The Federal Republic of Germany.- 1.5 Greece.- 1.6 The Republic of Ireland.- 1.7 Italy.- 1.8 The Netherlands.- 1.9 Portugal.- 1.10 Spain.- 1.11 The United Kingdom.- Section Two: Biotechnology in Latin America.- Comments by His Excellency Mr. Luis Ramiro Alfonsin, Ambassador of Argentina to the EEC.- 2.0 Overview of Latin American Activities in Biotechnology.- 2.1 Argentina.- 2.2 Brazil.- 2.3 Mexico.- 2.4 The Andean Countries.- 2.4.1 Andean Technology Policy: Its Nature and Far-Reaching Effects.- 2.4.2 Guidelines for a Reorientation of the Andean Scientific and Technological Integration.- 2.4.3 Fields of Action of the New Andean Technological Policy.- 2.4.4 The Andean Programme of Biotechnology.- 2.4.5 National and Subregional Experiences.- 2.4.6 Andean-European Co-operation on Biotechnology.- Health in the Third World: The Role of International Co-operation.- Conclusions and Analysis.
by "Nielsen BookData"